Abstract:【Abstract】Objective To explore the effect and mechanism of longchain noncoding RNA TTNAS1 on breast cancer growth and metastasis. Methods QRTPCR was used to detect the expression level of TTNAS1 in 5 types of breast cancer cells. Transfection of breast cancer cells with shRNA inhibits the expression of TTN AS1. After transfection, CCK8 tested the proliferation ability of each group of cells. Western blot was used to detect the relative expression levels of apoptosisrelated proteins Bcl2, Bax, CleavedCaspase3, and Caspase3. The miRcode database predicts the binding sites of lncRNA TTNAS1 and miR1345p. The double luciferase reporter gene experiment verified the targeting relationship between lncRNA TTNAS1 and miR1345p. Transfection of shRNA in breast cancer cells inhibits the expression of TTNAS1 while transfection of miR1345p inhibitor inhibits the expression of miR1345p, and then detects changes in cell proliferation, apoptosis, migration ability and apoptosisrelated protein expression. Results TTN AS1 is highly expressed in 5 types of breast cancer cells. After inhibiting the expression of TTNAS1, the proliferation and migration ability of breast cancer cells was significantly downregulated, the level of cell apoptosis was significantly increased, the expression of Bcl2 was significantly downregulated, and the expression of Bax and CleavedCaspase3 were significantly upregulated (all P<0 05). miR1345p is the target gene of lncRNA TTNAS1, inhibiting the expression of TTNAS1 while inhibiting the expression of miR1345p cell proliferation and migration were significantly higher than that of the TTNAS1 group alone, and the level of cell apoptosis was significantly lower In the TTNAS1 group alone, the expression of apoptosisrelated proteins also showed significant changes (all P<005). Conclusion TTNAS1 regulates the proliferation, apoptosis, migration ability and expression of apoptosisrelated proteins of breast cancer cells through targeted inhibition of miR1345p.